Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH-Reference-Cited by-同舟云学术

Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH

Published:2013-02 Issue:2 Volume:131 Page:178-182
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Narverud Ingunn,Iversen Per Ole,Aukrust Pål,Halvorsen Bente,Ueland Thor,Johansen Siril G.,Nenseter Marit S.,Sandset Per Morten,Ulven Stine M.,Ose Leiv,Retterstøl Kjetil,Holven Kirsten B.

Funder

The Throne-Holst Foundation for Nutrition Research, Oslo, Norway

Norwegian Association of Heart and Lung Patients, Oslo, Norway

Blix Family Legacy, Oslo, Norway

Freia Chocolate Factory's Medical Foundation, Oslo, Norway

Johan H Andresen's Medical Foundation, University of Oslo, Oslo, Norway

Nordic centre of excellence SYSDIET

Publisher

Elsevier BV

Subject

Hematology

Reference31 articles.

1. Inflammation in atherosclerosis;Libby;Nature,2002

2. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease;Kannel;Lipids,2005

3. Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls;Blann;Atherosclerosis,2000

4. Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): association with the intimal-medial thickness of carotid arteries;Sakata;Atherosclerosis,2004

5. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study;Salomaa;Lancet,1999

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma legumain in familial hypercholesterolemia: associations with statin use and cardiovascular risk markers;Scandinavian Journal of Clinical and Laboratory Investigation;2024-02

2. Familial Hypercholesterolemia and Acute Coronary Syndromes: The Microbiota–Immunity Axis in the New Diagnostic and Prognostic Frontiers;Pathogens;2023-04-21

3. Considerations for treatment of lipid disorders during pregnancy and breastfeeding;Progress in Cardiovascular Diseases;2022-11

4. Management of familial hypercholesterolemia in pregnancy;Current Opinion in Lipidology;2021-10-06

5. Management Considerations for Lipid Disorders During Pregnancy;Current Treatment Options in Cardiovascular Medicine;2021-05-12